01 9AstraZeneca Canada Inc.
02 2Gowling Lafleur Henderson LLP
03 4Gowling WLG (Canada) LLP
01 42050812
02 42290521
03 12388322
04 12388325
05 52538419
01 15Ciclesonide
01 4 Suspension
02 9Metered Dose Aerosol
03 2Nasal Aerosol
01 42011-09-06
02 42018-05-18
03 22020-10-20
04 52024-09-15
Patent Expiration Date : 2020-10-20
Date Granted : 2007-09-18
Brand Name : OMNARIS
Patent Number : 2388325
Filing Date : 2000-10-20
Strength per Unit : 50 ?g
Dosage Form : Suspension
Human Or VET : Human
Route of Administration : Nasal
Patent Expiration Date : 2020-10-20
Date Granted : 2007-09-18
Patent Expiration Date : 2020-10-20
Date Granted : 2007-09-18
Brand Name : OMNARIS
Patent Number : 2388322
Filing Date : 2000-10-20
Strength per Unit : 50 ?g
Dosage Form : Suspension
Human Or VET : Human
Route of Administration : Nasal
Patent Expiration Date : 2020-10-20
Date Granted : 2007-09-18
Patent Expiration Date : 2011-09-06
Date Granted : 2003-07-29
Brand Name : OMNARIS
Patent Number : 2050812
Filing Date : 1991-09-06
Strength per Unit : 50 ?g
Dosage Form : Suspension
Human Or VET : Human
Route of Administration : Nasal
Patent Expiration Date : 2011-09-06
Date Granted : 2003-07-29
Patent Expiration Date : 2011-09-06
Date Granted : 2003-07-29
Brand Name : ALVESCO
Patent Number : 2050812
Filing Date : 1991-09-06
Strength per Unit : 100 ug
Dosage Form : Metered Dose Aerosol
Human Or VET : Human
Route of Administration : Inhalation
Patent Expiration Date : 2011-09-06
Date Granted : 2003-07-29
Patent Expiration Date : 2018-05-18
Date Granted : 2006-10-10
Brand Name : ALVESCO
Patent Number : 2290521
Filing Date : 1998-05-18
Strength per Unit : 100 ug
Dosage Form : Metered Dose Aerosol
Human Or VET : Human
Route of Administration : Inhalation
Patent Expiration Date : 2018-05-18
Date Granted : 2006-10-10
Patent Expiration Date : 2018-05-18
Date Granted : 2006-10-10
Brand Name : ALVESCO
Patent Number : 2290521
Filing Date : 1998-05-18
Strength per Unit : 200 ug
Dosage Form : Metered Dose Aerosol
Human Or VET : Human
Route of Administration : Inhalation
Patent Expiration Date : 2018-05-18
Date Granted : 2006-10-10
Patent Expiration Date : 2024-09-15
Date Granted : 2012-07-03
Brand Name : OMNARIS
Patent Number : 2538419
Filing Date : 2004-09-15
Strength per Unit : 50 ?g
Dosage Form : Suspension
Human Or VET : Human
Route of Administration : Nasal
Patent Expiration Date : 2024-09-15
Date Granted : 2012-07-03
Patent Expiration Date : 2024-09-15
Date Granted : 2012-07-03
Brand Name : ALVESCO
Patent Number : 2538419
Filing Date : 2004-09-15
Strength per Unit : 100 ug
Dosage Form : Metered Dose Aerosol
Human Or VET : Human
Route of Administration : Inhalation
Patent Expiration Date : 2024-09-15
Date Granted : 2012-07-03
Patent Expiration Date : 2024-09-15
Date Granted : 2012-07-03
Brand Name : ALVESCO
Patent Number : 2538419
Filing Date : 2004-09-15
Strength per Unit : 200 ug
Dosage Form : Metered Dose Aerosol
Human Or VET : Human
Route of Administration : Inhalation
Patent Expiration Date : 2024-09-15
Date Granted : 2012-07-03
Patent Expiration Date : 2011-09-06
Date Granted : 2003-07-29
Brand Name : ALVESCO
Patent Number : 2050812
Filing Date : 1991-09-06
Strength per Unit : 50 ?g
Dosage Form : Metered Dose Aerosol
Human Or VET : Human
Route of Administration : Inhalation
Patent Expiration Date : 2011-09-06
Date Granted : 2003-07-29
